Eli Lilly and Company (LLY) Trading Guide: Pip Value & Strategy (2026)

Before you click buy, you need to know the contract. LLY trades with a contract size of 1 share. Each pip is $0.01 and carries a pip value of $1 per contract. That means buying 50 contracts is 50 shares, and the spread alone costs you $60 (1.2 pips * $1 * 50).

With the share price swinging between $700 and $970, the nominal moves are huge. A 1% move on an $850 share is $8.50 per share. That's $850 on a 100-share position. Volume spikes to 10+ million shares on catalyst days like earnings or trial data, but liquidity evaporates outside the main session, blowing out that nice 1.2 pip spread.

You trade LLY for one reason: asymmetric event risk. This isn't a slow-moving blue chip; it's a proxy for the entire GLP-1 obesity drug theme. A competitor's trial result or an FDA comment can move it 5% in a day. I've personally caught a $12 move (1200 pips) on positive trial data, turning a modest position into a great week's profit in hours.

But here's what most miss: its reported beta is a lie. Bloomberg shows a 5-year beta near 0.4, suggesting it's less volatile than the market. In reality, it trades on pharma-specific news that beta doesn't capture. The stock dropped 6% in a session in August 2024 on a competitor's news — a move a standard beta model would never predict. You're not trading a stock; you're trading binary event outcomes with a trending bias.

Trade when the big money is active. For LLY, that's unequivocally the NYSE Regular Session. Everything else is a dangerous sideshow with wide spreads and unreliable fills.

For intraday trades, aim for 14:30–16:30 UTC. The momentum from the open is still there, and liquidity is peak. If you're holding overnight, you must accept gap risk. LLY gapped more than 3% at least six times in 2024. Don't pretend it won't happen to you.

Standard percentage stops fail on LLY because of gap risk. A 1% stop on an $850 stock is $8.50, or 850 pips. That seems wide until the stock opens -3% on an FDA announcement, blowing straight through it.

Here’s the math for a practical position size:

• Account: $10,000
• Risk per trade: 1% = $100
• Stop distance: 1% of $850 = $8.50 per share
• Position size: $100 / $8.50 = ~11 shares

You need a multi-level defense:

• Initial Stop (0.3–0.5%): Catches a bad entry immediately.
• Catastrophic Stop (1.5–2%): Your 'oh crap' line for overnight gaps.
• Trailing Stop (ATR-based): Activates after a 1%+ profit to lock in gains.

Calendar management is non-negotiable. Know the quarterly earnings dates (late Jan, Apr, Jul, Oct) and the FDA Advisory Committee calendar. Holding through these without a plan is donating money to the market. I learned this the hard way holding through what I thought was minor news, only to watch $2,500 evaporate at the open.

Traders blow up on LLY in predictable ways. Don't be one of them.

• Trusting the Beta: Using a 0.4 beta for position sizing is a recipe for being undercapitalized when real news hits. Size for event volatility, not historical correlation.
• Trading the Thin Sessions: Chasing pre-market moves is a sucker's game. The liquidity isn't there, and the open often reverses it. Wait for 14:30 UTC.
• Using Tight Stops: A 50-pip ($0.50) stop on an $850 stock is noise. It will get taken out by normal intraday wobble before any real move develops.
• Ignoring the Calendar: This is the big one. LLY is an event stock. Not knowing when earnings or FDA decisions are scheduled is professional negligence.
• Overleveraging the Nominal Move: Because the pip value is $1, a 1000-pip move feels like a $1000 win per contract. It's easy to size too big and not respect the equivalent dollar risk at these share prices.